Drug Shortage Report for LUTATHERA
| Report ID | 160113 |
| Drug Identification Number | 02484552 |
| Brand name | LUTATHERA |
| Common or Proper name | Lutetium (177Lu) oxodotreotide |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | LUTETIUM |
| Strength(s) | 370MBq |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 370 MBq in 1 single dose vial |
| ATC code | V10XX |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-05-02 |
| Actual start date | 2022-05-02 |
| Estimated end date | 2022-06-13 |
| Actual end date | 2022-06-13 |
| Shortage status | Resolved |
| Updated date | 2022-06-14 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2022-06-14 | English | Compare |
| v3 | 2022-06-07 | English | Compare |
| v2 | 2022-05-06 | French | Compare |
| v1 | 2022-05-06 | English | Compare |
Showing 1 to 4 of 4